...
首页> 外文期刊>Journal of Applied Polymer Science >Doxorubicin-loaded poly(butylcyanoacrylate) nanoparticles produced by emulsifier-free emulsion polymerization
【24h】

Doxorubicin-loaded poly(butylcyanoacrylate) nanoparticles produced by emulsifier-free emulsion polymerization

机译:通过无乳化剂乳液聚合制备的负载阿霉素的聚(氰基丙烯酸丁酯)纳米颗粒

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Doxorubicin-loaded poly(butylcyanoacrylate) (PBCA) nanoparticles (NPs) were prepared by an emulsifier-free emulsion polymerization technique. The pH values of the polymerization medium and the weight ratios of doxorubicin to butylcyanoacrylate had a significant effect on the mean particle size. The particle diameter determined by transmission electron microscopy showed that the nanoparticles were predominantly less than 50 nm. Drug loading and entrapment efficiency increased with increasing pH of the medium. The surface tension of the polymerization media increased with increasing polymerization time and reached a plateau after 4 h, Doxorubicin-loaded PBCA NPs carried a positive charge, and the zeta potential of drug-loaded nanoparticles increased with the increase of the polymerization pH. Molecular weight, analyzed by gel permeation chromatography, showed that the nanoparticles mainly consisted of oligomers of PBCA. The release rate of doxorubicin from nanoparticles in biological phosphate buffer was very slow, with a half-life of 111.43 h. The results indicate that drug-loaded nanoparticles can be prepared by an emulsifier-free emulsion polymerization technique and that the resulting nanoparticles might be suitable for targeting drug delivery vehicles for clinical application. (C) 2000 John Wiley & Sons, Inc. [References: 32]
机译:通过无乳化剂乳液聚合技术制备了负载阿霉素的聚(氰基丙烯酸丁酯)(PBCA)纳米颗粒(NPs)。聚合介质的pH值以及阿霉素与氰基丙烯酸丁酯的重量比对平均粒径有重大影响。通过透射电子显微镜确定的粒径表明,纳米颗粒主要小于50nm。载药量和包封率随培养基pH值的增加而增加。聚合介质的表面张力随聚合时间的增加而增加,并在4 h后达到平稳,负载阿霉素的PBCA NPs带正电荷,负载药物的纳米粒子的Zeta电位随聚合pH值的增加而增加。通过凝胶渗透色谱分析的分子量表明,该纳米颗粒主要由PBCA的低聚物组成。阿霉素从纳米颗粒在生物磷酸盐缓冲液中的释放速度非常慢,半衰期为111.43小时。结果表明,可以通过无乳化剂乳液聚合技术制备载有药物的纳米颗粒,并且所得的纳米颗粒可能适用于靶向用于临床应用的药物递送载体。 (C)2000 John Wiley&Sons,Inc. [参考:32]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号